{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0","value":"0"},{"groupId":"OG001","spread":"41.3","value":"45.8"},{"groupId":"OG002","spread":"53.8","value":"316"},{"groupId":"OG003","spread":"38.4","value":"1620"},{"groupId":"OG004","spread":"30.9","value":"4510"},{"groupId":"OG005","spread":"25.5","value":"24800"},{"groupId":"OG006","spread":"31.7","value":"55200"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"10"}],"units":"Participants"}],"description":"Cmax was obtained from the plasma concentration versus time data after IV administration of IPH2101.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"IV Bolus","id":"OG000","title":"IPH2101 0.0003 mg/kg"},{"description":"IV Bolus","id":"OG001","title":"IPH2101 0.003 mg/kg"},{"description":"IV Bolus","id":"OG002","title":"IPH2101 0.015 mg/kg"},{"description":"IV 1 hour infusion","id":"OG003","title":"IPH2101 0.075 mg/kg"},{"description":"IV 1 hour infusion","id":"OG004","title":"IPH2101 0.3 mg/kg"},{"description":"IV 1 hour infusion","id":"OG005","title":"IPH2101 1 mg/kg"},{"description":"IV 1 hour infusion","id":"OG006","title":"IPH2101 3 mg/kg"}],"paramType":"GEOMETRIC_MEAN","reportingStatus":"POSTED","timeFrame":"Anti-KIR (1-7F9) concentrations were measured prior to infusion at 0.167, 1, 3, 6, 12 and 24 hours and then on Days 7, 14 and 21 after the start of the first dose administration","title":"Maximum Plasma Concentration (Cmax) of IPH2101 After Cycle 1 Administration","type":"SECONDARY","unitOfMeasure":"ng/mL"}